Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Pharma Industry Face Unprecedented Price Pressure in Expanded 4+7 Tender as Gove... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on MNC performance at the latest expanded 4+7 tender, unprec... (9/30/2019) Pharmaceutical Innovation in the APAC Region (11/13/2019) As Trade War Continues, Pharma Companies Prepare for Alternatives (11/13/2019) A Summary of The Latest Amendments to the Guidelines for Patent Examination In China (11/12/2019) Restrictions and Conflicts - Challenges Faced by Pharmaceutical Trademarks In China (11/7/2019) Top Execs from AstraZeneca, Roche, Sanofi and GSK Tout China Investments at Import Expo (11/7/2019) Finding the Right Formula for China Business Amid Cloudy Outlook (11/4/2019) Enforcing Patents - China's Bad Faith Entities List (10/31/2019) Newly Revised Guidelines For Patent Examination Will Come Into Force As Of November 1 (10/31/2019) In Generic Drug Plants in China and India, Data Falsification Is Still A Problem (10/30/2019) China's $132 Billion Market Pushes Big Pharma Into Uncharted Territory (10/24/2019) The Life Sciences Regulatory Regime in China (10/24/2019) China Is Striving for the World's Best, Cheapest Healthcare (10/22/2019) China's Blueprint for Its Pharmaceutical Sector (10/16/2019) China's Drug Administrative Law Amended to Encourage Innovation and Deter Safety Violations (10/16/2019) Hainan Medical Tourism Zone: New Pilot Policies Rolled Out (10/10/2019) China Issues the Provisions for Health I...  (11/13/2019) Upcoming Event: IDF Congress 2019  (11/13/2019) (free) CDE Solicits Comments on the Working Pro...  (11/13/2019) Upcoming Event: Phar-East 2020  (11/13/2019) (free) LEO Pharma, HitGen to Develop Novel Clas...  (11/13/2019) Hua Medicine's Pivotal Phase III Monothe...  (11/13/2019) Qpex Biopharma, Brii Biosciences Ink Ant...  (11/13/2019) Upcoming Event: 2019 Pharma CI+MR Asia C...  (11/12/2019) (free) NMPA Announces Implementation of 15 Seri...  (11/12/2019) GSK Announces Chinese Approval of Triple...  (11/12/2019) GE Healthcare and Akeso Expedite Antibod...  (11/12/2019) (free) Chi-Med Announces NDA Acceptance for Nov...  (11/11/2019) Akesobio Presents P1 Data from First-in-...  (11/11/2019) Novaliq, Hengrui Enter China licensing D...  (11/11/2019) NHSA Initiates A New Round of Negotiatio...  (11/11/2019) Pfizer to Absorb Mylan, Creating Global Generic Powerhou... PhRMA Calls for Trade Deals That Force Countries to Pay ... IQVIA: Global Pharma to Grow Slower in the Next Five Yea... Pfizer and GSK Announce JV to Create a Global Consumer H... Top 25 Global Pharmaceutical Companies by Market Cap 201... Global and Chinese OTC Market Growth Slows in MAT Q2/2019 SMEI: Chinese County Level Public Hospital Drug Sales Up 7.8% i... SMEI: Chinese Township Health Center Drug Sales Up 9.3% in 2018... SMEI: Chinese Offline Retail Pharmacy Drug Sales Up 6.8% in 201... SMEI: Chinese Online Pharmacy Drug Sales Up 41.4% in 2018 CDE Solicits Comments on the Working Procedures for Risk Con... LEO Pharma, HitGen to Develop Novel Class of Derma Drugs Qpex Biopharma, Brii Biosciences Ink Anti-infective Alliance... GSK Announces Chinese Approval of Triple COPD Therapy Treleg... GE Healthcare and Akeso Expedite Antibody Manufacturing in C... NMPA Announces Implementation of 15 Series E and 13 Seri... CDE Extends Deadline for Public Comments on Nine Draft D... CDE Solicits Comments on the Technical Guidelines for Cl... CDE Solicits Public Comments on the Working Process for ... CDE Solicits Public Comments on the Working Process for ... CNIPA Issues Administrative Measures on List of Serious Viol... Centrient Pharma Initiates a Second Patent Litigation in Ind... Couple Stole Trade Secrets from U.S. Children's Hospital to ... China Adopts New Amendment of PRC Drug Administration Law New Revision Draft of Drug Administration Law Submitted to t... Nikkei: Japan's Generic Drugmakers Have A China Dependen... Korea's Growing Reliance on China for API Supply Flagged... WuXi STA's Jinshan Facility Passes EMA Inspection Novartis Disposes Suzhou Novartis PharmTech in Changshu ... FDA Warns Chinese API Producer Yino Hua Medicine's Pivotal Phase III Monotherapy Trial of Do... Chi-Med Announces NDA Acceptance for Novel Drug Surufati... Akesobio Presents P1 Data from First-in-class Bispecific... VISEN Announces China Phase 3 Clinical Study Initiation ... NMPA Approves the World's First Seaweed-based Alzheimer'... China Issues the Provisions for Health Insurance Adminis... NHSA Initiates A New Round of Negotiation for the NRDL A... NDRC Issues the Work Plan for Building Regional Medical ... NHC Issues Notice to Establish National and Regional Men... China Issues Opinions for Establishing / Improving Senio... Recent Executive Moves Recent Executive Moves Sino Biopharma Founders Makes Son Eric Tse A Major Shareho... Recent Executive Moves 173 Pharma Tycoons Made It to the LEXUS-Hurun China Rich L... Upcoming Event: IDF Congress 2019 Upcoming Event: Phar-East 2020 Upcoming Event: 2019 Pharma CI+MR Asia Conference &a... Upcoming Event: 2nd International Women Health and Breas... Upcoming Event: Global Pharma Supply Chain Innovation Su... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Publishes the China Phar...   WiCON to Hold Pharma China Ann...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links